JPWO2024043334A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2024043334A5 JPWO2024043334A5 JP2024542889A JP2024542889A JPWO2024043334A5 JP WO2024043334 A5 JPWO2024043334 A5 JP WO2024043334A5 JP 2024542889 A JP2024542889 A JP 2024542889A JP 2024542889 A JP2024542889 A JP 2024542889A JP WO2024043334 A5 JPWO2024043334 A5 JP WO2024043334A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- optionally substituted
- amino
- piperazin
- ethan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026046953A JP2026098108A (ja) | 2022-08-26 | 2026-03-23 | 新規なピペラジン誘導体又はその塩及び医薬組成物 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022135257 | 2022-08-26 | ||
| PCT/JP2023/030733 WO2024043334A1 (ja) | 2022-08-26 | 2023-08-25 | 新規なピペラジン誘導体又はその塩及び医薬組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026046953A Division JP2026098108A (ja) | 2022-08-26 | 2026-03-23 | 新規なピペラジン誘導体又はその塩及び医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2024043334A1 JPWO2024043334A1 (cg-RX-API-DMAC7.html) | 2024-02-29 |
| JPWO2024043334A5 true JPWO2024043334A5 (cg-RX-API-DMAC7.html) | 2025-05-09 |
Family
ID=90013519
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024542889A Pending JPWO2024043334A1 (cg-RX-API-DMAC7.html) | 2022-08-26 | 2023-08-25 | |
| JP2026046953A Pending JP2026098108A (ja) | 2022-08-26 | 2026-03-23 | 新規なピペラジン誘導体又はその塩及び医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026046953A Pending JP2026098108A (ja) | 2022-08-26 | 2026-03-23 | 新規なピペラジン誘導体又はその塩及び医薬組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250326744A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4578849A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JPWO2024043334A1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN119816484A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023331216A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024043334A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025178125A1 (ja) * | 2024-02-22 | 2025-08-28 | 富士フイルム株式会社 | 新規なピペラジン誘導体又はその塩 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09241241A (ja) * | 1996-03-08 | 1997-09-16 | Roussel Morishita Kk | N−(1−置換−4−ピペリジル)ベンズアミド誘導体 |
| JPWO2002087589A1 (ja) * | 2001-04-26 | 2004-08-12 | 第一製薬株式会社 | 薬剤排出ポンプ阻害薬 |
| US6689782B2 (en) * | 2001-07-16 | 2004-02-10 | Essential Therapeutics, Inc. | Fungal efflux pump inhibitors |
| CN1158270C (zh) * | 2001-09-26 | 2004-07-21 | 四川大学 | 具有钙离子拮抗作用的双哌嗪类衍生物 |
| JP2005162726A (ja) * | 2003-01-24 | 2005-06-23 | Tanabe Seiyaku Co Ltd | ピラゾロピリミジン化合物およびその製法 |
| WO2007016496A2 (en) * | 2005-08-02 | 2007-02-08 | Neurogen Corporation | Dipiperazinyl ketones and related analogues |
| KR20080061613A (ko) * | 2006-12-28 | 2008-07-03 | (주) 비엔씨바이오팜 | 2-(메틸티오)피리미딘 유도체, 그 제조방법 및 이를포함하는 항바이러스용 약학적 조성물 |
| CN101070308B (zh) * | 2007-06-19 | 2011-05-04 | 天津药物研究院 | 异噁唑啉衍生物及其用途 |
| CN101361741B (zh) * | 2008-09-22 | 2011-07-27 | 天津药物研究院 | 异噁唑啉类衍生物抗肿瘤新用途 |
| CN104610160A (zh) * | 2013-11-04 | 2015-05-13 | 南京大学 | 含哌嗪环的5-硝基咪唑类衍生物及其制备与在抗菌药物中的应用 |
| EP3867242A1 (en) * | 2018-10-15 | 2021-08-25 | Nurix Therapeutics, Inc. | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway |
| CA3160713A1 (en) * | 2019-12-04 | 2021-06-10 | Nurix Therapeutics, Inc. | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway |
| CN113527227B (zh) * | 2020-04-15 | 2024-06-21 | 四川弘远药业有限公司 | 一种卡利拉嗪的制备方法 |
| TW202222311A (zh) * | 2020-08-26 | 2022-06-16 | 美商塔維達治療公司 | 結合熱休克蛋白90(hsp90)之共軛體和彼之調製劑 |
| CN112358466B (zh) * | 2020-10-10 | 2021-10-26 | 广东省微生物研究所(广东省微生物分析检测中心) | 1,2,4-三唑-诺氟沙星杂合体及其制备方法和应用 |
| CN112592339B (zh) * | 2020-12-22 | 2022-06-07 | 广东省微生物研究所(广东省微生物分析检测中心) | 1,3,4-恶二唑-2(3h)-硫酮-诺氟沙星杂合体及其制备方法和应用 |
| WO2023055952A1 (en) * | 2021-09-29 | 2023-04-06 | C4 Therapeutics, Inc. | Neurotrophic tyrosine receptor kinase (ntrk) degrading compounds |
-
2023
- 2023-08-25 EP EP23857442.0A patent/EP4578849A4/en active Pending
- 2023-08-25 CN CN202380062202.6A patent/CN119816484A/zh active Pending
- 2023-08-25 AU AU2023331216A patent/AU2023331216A1/en active Pending
- 2023-08-25 WO PCT/JP2023/030733 patent/WO2024043334A1/ja not_active Ceased
- 2023-08-25 JP JP2024542889A patent/JPWO2024043334A1/ja active Pending
-
2025
- 2025-02-24 US US19/061,542 patent/US20250326744A1/en active Pending
-
2026
- 2026-03-23 JP JP2026046953A patent/JP2026098108A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2356893C2 (ru) | Ингибиторы фосфодиэстеразы 4 | |
| JP2021529812A5 (cg-RX-API-DMAC7.html) | ||
| RU2008108984A (ru) | Терапевтический агент от диабета | |
| JP2011526913A5 (ja) | キナゾリン化合物及び同化合物を含む治療薬 | |
| JP2010520307A5 (cg-RX-API-DMAC7.html) | ||
| JP2004538285A5 (cg-RX-API-DMAC7.html) | ||
| FR2840897A1 (fr) | Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique | |
| RU2007134380A (ru) | Антибактериальные производные пиперидина | |
| JP2005533071A5 (cg-RX-API-DMAC7.html) | ||
| TNSN07361A1 (en) | 3,4-substituted pyrrolidine derivatives for the treatment of hypertension | |
| RU2004137279A (ru) | Производные дифенилазетидинона для лечения нарушений метаболизма липидов | |
| JP2004115534A5 (cg-RX-API-DMAC7.html) | ||
| JP2021515004A5 (cg-RX-API-DMAC7.html) | ||
| RU2017145930A (ru) | МОДУЛЯТОРЫ ROR ГАММА (RORγ) | |
| PT2420491E (pt) | Compostos de piperidina 3,5-substituída como inibidores de renina | |
| JP2020507606A5 (cg-RX-API-DMAC7.html) | ||
| JP2010536821A5 (cg-RX-API-DMAC7.html) | ||
| JP2016516028A5 (cg-RX-API-DMAC7.html) | ||
| RU2007147344A (ru) | Новые производные 2-азетидинона для лечения гиперлипидемических заболеваний | |
| JP2019529359A5 (cg-RX-API-DMAC7.html) | ||
| RU2007147338A (ru) | Новые производные 2-азетидинона и их применение в качестве ингибиторов всасывания холестерина для лечения гиперлипидемии | |
| JP2022522890A5 (cg-RX-API-DMAC7.html) | ||
| JP2006501248A5 (cg-RX-API-DMAC7.html) | ||
| MA26858A1 (fr) | Acides ox(adi)azolyl-hydroxamiques utiles comme inhibiteurs de procollagene c-proteinase. | |
| RU2008136763A (ru) | Гетероциклические противовирусные соединения |